Saquinavir [clinicaltrials_resource:02194e43d8c649b6cc209511c5df83ee]
eligibility for clinicaltrials:NCT01835145 [clinicaltrials_resource:22853b78666e9653a2ef02f18dcab961]eligibility for clinicaltrials:NCT00107536 [clinicaltrials_resource:273f28a85c6566d76ff76854cd53b9fb]eligibility for clinicaltrials:NCT00134069 [clinicaltrials_resource:31c44eb02996a6c0ff1a0b62791f3b16]eligibility for clinicaltrials:NCT00617708 [clinicaltrials_resource:5779b97f6e8f19f4261bc4fbf6ffca8f]eligibility for clinicaltrials:NCT02066181 [clinicaltrials_resource:b75bbb3aebffbab9512c0286dff621a7]eligibility for clinicaltrials:NCT00070525 [clinicaltrials_resource:bbc57e24ec459e18f6e64dc2c331a766]eligibility for clinicaltrials:NCT00119236 [clinicaltrials_resource:d8177edb3af609f1c135ac1b3cd473fc]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year [clinicaltrials:NCT00000848]A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir [clinicaltrials:NCT00000892]The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir [clinicaltrials:NCT00000898]Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients [clinicaltrials:NCT00000906]A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children [clinicaltrials:NCT00000913]Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns [clinicaltrials:NCT00000920]A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood [clinicaltrials:NCT00000941]Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC [clinicaltrials:NCT00001040]The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001087]A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients [clinicaltrials:NCT00001094]Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir [clinicaltrials:NCT00001133]A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease. [clinicaltrials:NCT00002111]A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs [clinicaltrials:NCT00002162]A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients [clinicaltrials:NCT00002178]A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient [clinicaltrials:NCT00002184]A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients [clinicaltrials:NCT00002190]Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients [clinicaltrials:NCT00002229]A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine [clinicaltrials:NCT00002333]A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment [clinicaltrials:NCT00002334]The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection [clinicaltrials:NCT00002347]A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs [clinicaltrials:NCT00002367]A Study of 141W94 in Combination With Other Anti-HIV Drugs [clinicaltrials:NCT00002372]A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients [clinicaltrials:NCT00002374]A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients [clinicaltrials:NCT00002378]The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children [clinicaltrials:NCT00002380]A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients [clinicaltrials:NCT00002382]A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients [clinicaltrials:NCT00002383]A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease [clinicaltrials:NCT00002397]The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs [clinicaltrials:NCT00002425]A Study to Compare Two Anti-HIV Drug Combinations [clinicaltrials:NCT00002447]A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients [clinicaltrials:NCT00002448]Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00003008]Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment [clinicaltrials:NCT00004584]Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers [clinicaltrials:NCT00005762]clinicaltrials:NCT00035932Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor [clinicaltrials:NCT00038519]Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART [clinicaltrials:NCT00038532]Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects [clinicaltrials:NCT00043953]Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers [clinicaltrials:NCT00050180]clinicaltrials:NCT00051831
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Saquinavir [clinicaltrials_resource:02194e43d8c649b6cc209511c5df83ee]
Bio2RDF identifier
02194e43d8c649b6cc209511c5df83ee
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:02194e43d8c649b6cc209511c5df83ee
identifier
clinicaltrials_resource:02194e43d8c649b6cc209511c5df83ee
title
Saquinavir
@en
type
label
Saquinavir [clinicaltrials_resource:02194e43d8c649b6cc209511c5df83ee]
@en